305 related articles for article (PubMed ID: 20821387)
1. Prodrugs: Some thoughts and current issues.
Stella VJ
J Pharm Sci; 2010 Dec; 99(12):4755-65. PubMed ID: 20821387
[TBL] [Abstract][Full Text] [Related]
2. Chemistry-enabled drug delivery (prodrugs): recent progress and challenges.
Clas SD; Sanchez RI; Nofsinger R
Drug Discov Today; 2014 Jan; 19(1):79-87. PubMed ID: 23993918
[TBL] [Abstract][Full Text] [Related]
3. Prodrug strategies to overcome poor water solubility.
Stella VJ; Nti-Addae KW
Adv Drug Deliv Rev; 2007 Jul; 59(7):677-94. PubMed ID: 17628203
[TBL] [Abstract][Full Text] [Related]
4. Strategies to improve oral drug bioavailability.
Gomez-Orellana I
Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in prodrugs as drug delivery systems.
Lin C; Sunkara G; Cannon JB; Ranade V
Am J Ther; 2012 Jan; 19(1):33-43. PubMed ID: 21150770
[TBL] [Abstract][Full Text] [Related]
6. Prodrugs: design and clinical applications.
Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
[TBL] [Abstract][Full Text] [Related]
7. Prodrug approaches for enhancing the bioavailability of drugs with low solubility.
Müller CE
Chem Biodivers; 2009 Nov; 6(11):2071-83. PubMed ID: 19937841
[TBL] [Abstract][Full Text] [Related]
8. Prodrug design of phenolic drugs.
Férriz JM; Vinsová J
Curr Pharm Des; 2010; 16(18):2033-52. PubMed ID: 20443775
[TBL] [Abstract][Full Text] [Related]
9. Diverse approaches for the enhancement of oral drug bioavailability.
Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
[TBL] [Abstract][Full Text] [Related]
10. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
Jana S; Mandlekar S; Marathe P
Curr Med Chem; 2010; 17(32):3874-908. PubMed ID: 20858214
[TBL] [Abstract][Full Text] [Related]
11. Current prodrug design for drug discovery.
Hsieh PW; Hung CF; Fang JY
Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical property trends of marketed prodrugs.
Landis MS
Ther Deliv; 2013 Feb; 4(2):225-37. PubMed ID: 23343161
[TBL] [Abstract][Full Text] [Related]
13. Novel prospective in colon specific drug delivery system.
Bansal V; Malviya R; Malaviya T; Sharma PK
Polim Med; 2014; 44(2):109-18. PubMed ID: 24967782
[TBL] [Abstract][Full Text] [Related]
14. The Prodrug Approach: A Successful Tool for Improving Drug Solubility.
Jornada DH; dos Santos Fernandes GF; Chiba DE; de Melo TR; dos Santos JL; Chung MC
Molecules; 2015 Dec; 21(1):42. PubMed ID: 26729077
[TBL] [Abstract][Full Text] [Related]
15. Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach.
Dahan A; Khamis M; Agbaria R; Karaman R
Expert Opin Drug Deliv; 2012 Aug; 9(8):1001-13. PubMed ID: 22703376
[TBL] [Abstract][Full Text] [Related]
16. Amino acids as promoieties in prodrug design and development.
Vig BS; Huttunen KM; Laine K; Rautio J
Adv Drug Deliv Rev; 2013 Oct; 65(10):1370-85. PubMed ID: 23099277
[TBL] [Abstract][Full Text] [Related]
17. Drug targeting using conjugates: the importance of pharmaceutical chemistry.
Byrn SR; Stowell JG
J Drug Target; 1995; 3(4):239-41. PubMed ID: 8820996
[No Abstract] [Full Text] [Related]
18. Targeted prodrug design to optimize drug delivery.
Han HK; Amidon GL
AAPS PharmSci; 2000; 2(1):E6. PubMed ID: 11741222
[TBL] [Abstract][Full Text] [Related]
19. Prodrugs - Recent approvals and a glimpse of the pipeline.
Rautio J; Kärkkäinen J; Sloan KB
Eur J Pharm Sci; 2017 Nov; 109():146-161. PubMed ID: 28782609
[TBL] [Abstract][Full Text] [Related]
20. Prodrugs--from serendipity to rational design.
Huttunen KM; Raunio H; Rautio J
Pharmacol Rev; 2011 Sep; 63(3):750-71. PubMed ID: 21737530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
